nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfacalcidol—VDR—Ovarian Infertility Genes—GDF9—polycystic ovary syndrome	0.0464	0.0548	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—SRD5A1—polycystic ovary syndrome	0.0334	0.0394	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—STAR—polycystic ovary syndrome	0.0318	0.0376	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.0271	0.032	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.0247	0.0292	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.0241	0.0285	CbGpPWpGaD
Alfacalcidol—VDR—Validated transcriptional targets of deltaNp63 isoforms—HELLS—polycystic ovary syndrome	0.022	0.026	CbGpPWpGaD
Alfacalcidol—CYP27B1—vagina—polycystic ovary syndrome	0.0217	0.161	CbGeAlD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—SRD5A1—polycystic ovary syndrome	0.021	0.0248	CbGpPWpGaD
Alfacalcidol—CYP27B1—endocrine gland—polycystic ovary syndrome	0.0203	0.151	CbGeAlD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—STAR—polycystic ovary syndrome	0.02	0.0236	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.0191	0.0225	CbGpPWpGaD
Alfacalcidol—VDR—Ovarian Infertility Genes—LHCGR—polycystic ovary syndrome	0.0178	0.021	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.0177	0.0209	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.017	0.0201	CbGpPWpGaD
Alfacalcidol—GC—endocrine gland—polycystic ovary syndrome	0.0169	0.125	CbGeAlD
Alfacalcidol—VDR—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.0164	0.0193	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.0155	0.0183	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.0152	0.0179	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—CYP19A1—polycystic ovary syndrome	0.014	0.0166	CbGpPWpGaD
Alfacalcidol—VDR—Ovarian Infertility Genes—FSHR—polycystic ovary syndrome	0.013	0.0154	CbGpPWpGaD
Alfacalcidol—VDR—adrenal cortex—polycystic ovary syndrome	0.0124	0.0919	CbGeAlD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.012	0.0141	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.0111	0.0131	CbGpPWpGaD
Alfacalcidol—VDR—uterus—polycystic ovary syndrome	0.0102	0.0756	CbGeAlD
Alfacalcidol—VDR—pituitary gland—polycystic ovary syndrome	0.00999	0.0742	CbGeAlD
Alfacalcidol—VDR—adipose tissue—polycystic ovary syndrome	0.00995	0.0739	CbGeAlD
Alfacalcidol—VDR—adrenal gland—polycystic ovary syndrome	0.00893	0.0663	CbGeAlD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—CYP19A1—polycystic ovary syndrome	0.0088	0.0104	CbGpPWpGaD
Alfacalcidol—Cholecalciferol—CYP11A1—polycystic ovary syndrome	0.00847	0.455	CrCbGaD
Alfacalcidol—GC—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.00842	0.00995	CbGpPWpGaD
Alfacalcidol—VDR—female gonad—polycystic ovary syndrome	0.00832	0.0618	CbGeAlD
Alfacalcidol—VDR—vagina—polycystic ovary syndrome	0.00827	0.0615	CbGeAlD
Alfacalcidol—VDR—Ovarian Infertility Genes—PGR—polycystic ovary syndrome	0.00804	0.0095	CbGpPWpGaD
Alfacalcidol—VDR—endocrine gland—polycystic ovary syndrome	0.00774	0.0575	CbGeAlD
Alfacalcidol—CYP27B1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00742	0.00876	CbGpPWpGaD
Alfacalcidol—CYP27B1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00732	0.00864	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptors—PGR—polycystic ovary syndrome	0.00701	0.00828	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00695	0.0082	CbGpPWpGaD
Alfacalcidol—Ergocalciferol—AR—polycystic ovary syndrome	0.00691	0.371	CrCbGaD
Alfacalcidol—CYP27B1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.0069	0.00814	CbGpPWpGaD
Alfacalcidol—CYP27B1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.0068	0.00804	CbGpPWpGaD
Alfacalcidol—VDR—Validated transcriptional targets of deltaNp63 isoforms—YAP1—polycystic ovary syndrome	0.00677	0.008	CbGpPWpGaD
Alfacalcidol—VDR—Ovarian Infertility Genes—CYP19A1—polycystic ovary syndrome	0.00643	0.00759	CbGpPWpGaD
Alfacalcidol—CYP27B1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00601	0.0071	CbGpPWpGaD
Alfacalcidol—VDR—Validated transcriptional targets of deltaNp63 isoforms—TOP2A—polycystic ovary syndrome	0.00591	0.00698	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—LIF—polycystic ovary syndrome	0.00567	0.0067	CbGpPWpGaD
Alfacalcidol—CYP27B1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00559	0.0066	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.00554	0.00654	CbGpPWpGaD
Alfacalcidol—VDR—Ovarian Infertility Genes—NCOR1—polycystic ovary syndrome	0.00547	0.00646	CbGpPWpGaD
Alfacalcidol—CYP27B1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00546	0.00644	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptors—AR—polycystic ovary syndrome	0.00545	0.00644	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00545	0.00643	CbGpPWpGaD
Alfacalcidol—CYP27B1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00539	0.00636	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.00529	0.00625	CbGpPWpGaD
Alfacalcidol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.00527	0.00622	CbGpPWpGaD
Alfacalcidol—CYP27B1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00524	0.00619	CbGpPWpGaD
Alfacalcidol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—polycystic ovary syndrome	0.00463	0.00546	CbGpPWpGaD
Alfacalcidol—CYP27B1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00442	0.00522	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.00441	0.00521	CbGpPWpGaD
Alfacalcidol—CYP27B1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.0044	0.00519	CbGpPWpGaD
Alfacalcidol—CYP27B1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00434	0.00513	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.00431	0.00509	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00431	0.00509	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00431	0.00509	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.00418	0.00494	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.00418	0.00494	CbGpPWpGaD
Alfacalcidol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NRG1—polycystic ovary syndrome	0.00395	0.00466	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00386	0.00456	CbGpPWpGaD
Alfacalcidol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—polycystic ovary syndrome	0.00383	0.00452	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00373	0.00441	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00361	0.00426	CbGpPWpGaD
Alfacalcidol—CYP27B1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00361	0.00426	CbGpPWpGaD
Alfacalcidol—CYP27B1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00357	0.00421	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00356	0.0042	CbGpPWpGaD
Alfacalcidol—VDR—Validated transcriptional targets of TAp63 isoforms—BAX—polycystic ovary syndrome	0.00351	0.00414	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.00348	0.00411	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00342	0.00404	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00342	0.00404	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.00341	0.00403	CbGpPWpGaD
Alfacalcidol—CYP27B1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00328	0.00387	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00326	0.00385	CbGpPWpGaD
Alfacalcidol—Cholecalciferol—CYP1A1—polycystic ovary syndrome	0.00322	0.173	CrCbGaD
Alfacalcidol—CYP27B1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00319	0.00377	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00315	0.00372	CbGpPWpGaD
Alfacalcidol—VDR—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.00297	0.00351	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00297	0.00351	CbGpPWpGaD
Alfacalcidol—CYP27B1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00297	0.00351	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00293	0.00346	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00278	0.00328	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.0027	0.00319	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.0027	0.00319	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.0027	0.00319	CbGpPWpGaD
Alfacalcidol—CYP27B1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00266	0.00314	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—NMNAT3—polycystic ovary syndrome	0.00265	0.00313	CbGpPWpGaD
Alfacalcidol—VDR—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.0026	0.00307	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00253	0.00299	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00247	0.00292	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—LPCAT2—polycystic ovary syndrome	0.00243	0.00287	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—SUOX—polycystic ovary syndrome	0.00243	0.00287	CbGpPWpGaD
Alfacalcidol—VDR—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.00241	0.00284	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.0024	0.00283	CbGpPWpGaD
Alfacalcidol—CYP27B1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00235	0.00277	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00232	0.00274	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.00229	0.00271	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00227	0.00268	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—ISYNA1—polycystic ovary syndrome	0.00226	0.00266	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—CCNB1—polycystic ovary syndrome	0.00222	0.00263	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.0022	0.0026	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00215	0.00254	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00206	0.00243	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00205	0.00242	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—ZNF205—polycystic ovary syndrome	0.00201	0.00238	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—ZNF430—polycystic ovary syndrome	0.00201	0.00238	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00195	0.00231	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—AKR1C2—polycystic ovary syndrome	0.00192	0.00227	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—TEAD2—polycystic ovary syndrome	0.00192	0.00227	CbGpPWpGaD
Alfacalcidol—CYP27B1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00189	0.00224	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00187	0.00221	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00184	0.00218	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00182	0.00214	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00174	0.00206	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—ADARB1—polycystic ovary syndrome	0.00171	0.00202	CbGpPWpGaD
Alfacalcidol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.00168	0.00198	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00167	0.00197	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—BAX—polycystic ovary syndrome	0.00164	0.00193	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—PNPLA2—polycystic ovary syndrome	0.00161	0.0019	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00159	0.00188	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00155	0.00183	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—SRD5A1—polycystic ovary syndrome	0.00152	0.0018	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00152	0.0018	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—SUOX—polycystic ovary syndrome	0.00152	0.0018	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.0015	0.00178	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—STAR—polycystic ovary syndrome	0.00145	0.00172	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00144	0.0017	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00142	0.00167	CbGpPWpGaD
Alfacalcidol—CYP27B1—Biological oxidations—POMC—polycystic ovary syndrome	0.00141	0.00167	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—LSM5—polycystic ovary syndrome	0.0014	0.00165	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00138	0.00164	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—SAP30L—polycystic ovary syndrome	0.0013	0.00153	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—HMMR—polycystic ovary syndrome	0.0013	0.00153	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00129	0.00153	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—HSD3B1—polycystic ovary syndrome	0.00124	0.00146	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00123	0.00145	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00122	0.00144	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—TEAD2—polycystic ovary syndrome	0.0012	0.00142	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—AKR1C2—polycystic ovary syndrome	0.0012	0.00142	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00116	0.00137	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00116	0.00137	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00114	0.00135	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—LHB—polycystic ovary syndrome	0.00113	0.00133	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—TEAD2—polycystic ovary syndrome	0.0011	0.0013	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—HSD3B2—polycystic ovary syndrome	0.0011	0.0013	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.0011	0.00129	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—SERPINE1—polycystic ovary syndrome	0.00108	0.00128	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—AKR1C1—polycystic ovary syndrome	0.00107	0.00126	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00101	0.00119	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—BCL2—polycystic ovary syndrome	0.000996	0.00118	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—SULT2A1—polycystic ovary syndrome	0.000982	0.00116	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000957	0.00113	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000957	0.00113	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—RRM2—polycystic ovary syndrome	0.000951	0.00112	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—YAP1—polycystic ovary syndrome	0.000917	0.00108	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—STAR—polycystic ovary syndrome	0.000913	0.00108	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000902	0.00107	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—NAMPT—polycystic ovary syndrome	0.000881	0.00104	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000876	0.00103	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—CYP11A1—polycystic ovary syndrome	0.00087	0.00103	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000864	0.00102	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—AKR1C3—polycystic ovary syndrome	0.000821	0.00097	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—HMMR—polycystic ovary syndrome	0.000814	0.000961	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—CYP17A1—polycystic ovary syndrome	0.000809	0.000955	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—RPL37A—polycystic ovary syndrome	0.000786	0.000929	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000776	0.000917	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000767	0.000906	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000744	0.000879	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000727	0.000859	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—LHB—polycystic ovary syndrome	0.000708	0.000836	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—TH—polycystic ovary syndrome	0.0007	0.000826	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000692	0.000817	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—SLC2A4—polycystic ovary syndrome	0.000681	0.000804	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00067	0.000791	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.00065	0.000768	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—CYP19A1—polycystic ovary syndrome	0.00064	0.000756	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000617	0.000728	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000602	0.000711	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—RRM2—polycystic ovary syndrome	0.000597	0.000705	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—YAP1—polycystic ovary syndrome	0.000576	0.00068	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—GNAS—polycystic ovary syndrome	0.000571	0.000674	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—NAMPT—polycystic ovary syndrome	0.000553	0.000653	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00055	0.000649	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000546	0.000645	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—NCOR1—polycystic ovary syndrome	0.000544	0.000643	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000542	0.00064	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—YAP1—polycystic ovary syndrome	0.000528	0.000623	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—CYP1A1—polycystic ovary syndrome	0.000516	0.000609	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000516	0.000609	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000508	0.0006	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—MTHFR—polycystic ovary syndrome	0.000481	0.000568	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000466	0.00055	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000465	0.000549	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—PGR—polycystic ovary syndrome	0.000461	0.000544	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—TH—polycystic ovary syndrome	0.000439	0.000519	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000427	0.000505	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.00042	0.000496	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000402	0.000475	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—PPARG—polycystic ovary syndrome	0.00039	0.00046	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—POMC—polycystic ovary syndrome	0.000385	0.000454	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—INS—polycystic ovary syndrome	0.000382	0.000452	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—GNAS—polycystic ovary syndrome	0.000359	0.000424	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—AR—polycystic ovary syndrome	0.000358	0.000423	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—NCOR1—polycystic ovary syndrome	0.000342	0.000403	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000324	0.000383	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—NCOR1—polycystic ovary syndrome	0.000313	0.00037	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—MTHFR—polycystic ovary syndrome	0.000302	0.000357	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—NR3C1—polycystic ovary syndrome	0.00029	0.000342	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—PPARG—polycystic ovary syndrome	0.000245	0.000289	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—POMC—polycystic ovary syndrome	0.000242	0.000285	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—INS—polycystic ovary syndrome	0.00024	0.000284	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—PPARG—polycystic ovary syndrome	0.000224	0.000265	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000202	0.000239	CbGpPWpGaD
